Search for: "Pfizer, Inc. (Pfizer)" Results 861 - 880 of 1,505
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
18 Apr 2008, 4:51 pm
Metro Area Medical Malpractice Law Blog Alaska, a leader in pet trusts - Florida attorney Danny Meek in his Pet Trust Law Blog Mississippi Supreme Court asked to interpret anti-concurrent cause in interlocutory appeal - Portland lawyer David Rossmiller of Dunn Carney in the firm's Insurance Coverage Law Blog Pfizer proves that biggest is not always best - Management consultant Cliff Mintz of BioInsights Inc. in his Bio Job Blog [read post]
12 Jan 2012, 4:30 am by Ray Mullman
 Another sponsor was pharmaceutical giant Pfizer Inc, which has an enormous financial stake in the outcome of the litigation. [read post]
23 May 2008, 5:38 am
" Chantix, made by Pfizer, Inc., was attacked in a study by a non-profit group on Wednesday for possible links to seizures, dizziness, heart irregularity, diabetes and more than 100 accidents. [read post]
28 Jun 2020, 7:52 am by Dan Bressler
” “Schulman was convicted by a New York federal jury on securities fraud and conspiracy charges for tipping off an investment adviser about Pfizer Inc. [read post]
5 Sep 2007, 1:33 pm
  Evidence rebutting a prima face case of obviousness can include: "evidence of unexpected results," Pfizer, Inc. v. [read post]
11 Dec 2014, 7:58 am by Gene Quinn
Mylan Inc. recently announced that its subsidiary Mylan Laboratories Limited has received tentative approval from the U.S. [read post]
8 May 2009, 8:00 am
(Property intangible) US: Supreme Court rules 9-0 that CAFC has jurisdiction to review case remanded by district court to state court: Carlsbad Technology Inc v HIF Bio, Inc et al (Managing Intellectual Property) (Patently-O) US: Anticipation by a laundry list of prophetic DNA sequences: In re Gleave (Holman's Biotech IP Blog) US: Reverse payment settlements and biotechnology (Holman's Biotech IP Blog) US: Biogen seeks review and correction of patent term adjustment… [read post]
18 Oct 2011, 9:32 am
Lang, general counsel and global vice president of legal affairs with Whole Foods Market Inc.; Ellen Rosenthal, vice president and assistant general counsel litigation/chief counsel at Pfizer Legal Alliance, Pfizer Inc.; and Erika Rottenberg, vice president, general counsel, and secretary for LinkedIn.Jelich will help provide practical guidance for in-house counsel and law firms seeking to bridge the gap between value and the cost of legal services.Currently based… [read post]
29 Jun 2015, 9:36 am
A futuristic Neil imagines a time when consumers’ psychological/neurological associations could be measured (also) for the sake of assess a trade marks’ reputation* Case management decisions in the Lyrica caseThe ongoing case between Warner-Lambert (a subsidiary of Pfizer) and Actavis concerning pregabalin (sold by Pfizer under the trade mark Lyrica, and by Actavis under the trade mark Lecaent) seems set to be the case of the year, Darren says. [read post]
10 Jun 2015, 6:00 am by JB
The NLDC wanted to redevelop an economically troubled neighborhood in conjunction with Pfizer, Inc., a major pharmaceutical firm that had set up a headquarters nearby and expected to benefit from the takings.The sad history of the project does indeed highlight some of the weaknesses of the Kelo decision. [read post]
17 Feb 2009, 6:53 am
  The case involves a group of investors (collectively, the “Plaintiffs”) alleging that Pharmacia, Inc. and its acquirer, Pfizer, Inc., (collectively, the “Defendants”) violated §§ 10(b) and 20(a) of the Securities Exchange Act of 1934 by making, with scienter, materially false statements about a clinical study of Celebrex. [read post]